Prognostic implication of creatine kinase release after elective percutaneous coronary intervention in the pre-IIb/IIIa antagonist era

American Heart Journal

Volumn 145, Issue 6, 2003, Pages 1006-1012

  Ghazzal, Ziyad ^a,b   Ashfaq, Salman ^a   Morris, Douglas C ^a   Douglas, John S ^a   Marshall, John J ^a   King III, Spencer B ^a   Weintraub, William S ^a  

^a Andreas Gruentzig Cardiovasc Center   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CREATINE KINASE BLOOD LEVEL; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; INTERVENTIONAL RADIOLOGY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY; ANGIOCARDIOGRAPHY; BLOOD; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; REFERENCE VALUE; RETROSPECTIVE STUDY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CREATINE KINASE; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REFERENCE VALUES; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0038121049     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(03)00095-4     Document Type: Article

References (25)

1. Ravkilde J, Nissen H, Mickley H, et al. Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. Am Heart J 1994;127:13-20.
2. Spadaro JJ, Ludbrook PA, Tiefenbrunn AJ. Paucity of subtle myocardial injury after angioplasty delineated with MB CK. Cathet Cardiovasc Diagn 1986;12:230-4.
3. Pauletto P, Piccolo D, Scannapieco G, et al. Changes in myoglobin, creatine kinase-MB after percutaneous transluminal coronary angioplasty for stable angina pectoris. Am J Cardiol 1987;59:999-1000.
4. Kong TQ, Davidson CJ, Meyers SN, et al. Prognostic implication of creatine kinase elevation following elective coronary artery. JAMA 1997;277:461-6.
5. Abdelmeguid AE, Topol EJ, Whitlow PL, et al. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 1996;4:1528-36.
6. Abdelmeguid AE, Ellis SG, Sapp SK, et al. Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions. Am Heart J 1996;131:1097-105.
7. Hong MK, Mehran R, Dangas G, et al. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 1999;100:2400-5.
8. Saucedo JF, Mehran R, Dangas G, et al. Long-term clinical events following creatine kinase-myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol 2000;35:1134-41.
9. Klein LW, Kramer BL, Howard E, et al. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty. J Am Coll Cardiol 1991;17:621-6.
10. Oh JK, Shub C, Ilstrup DM, et al. Creatine kinase release after successful percutaneaus transluminal coronary angioplasty. Am Heart J 1985;109:1225-31.
11. Kugelmass AD, Cohen CJ, Moscucci M, et al. Elevation of creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting. Am J Cardiol 1994;74:748-54.
12. Kini A, Marmur JD, Kini S, et al. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention. J Am Coll Cardiol 1999;34:663-71.
13. Stone G, Mehran R, Dangas G, et al. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention. Circulation 2001;104:642-7.
14. Antman E, Bassand J, Klein W, et al. Myocardial infarction redefined a consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. The Joint European Society of Cardiology/American College of Cardiology Committee. J Am Coll Cardiol 2000;36:959-69.
15. Smith SC, Dove JT, Jacobs AK, et al. ACC/AHA guidelines for percutaneaus coronary intervention (revision of the 1993 PTCA guidelines). J Am Coll Cardiol 2001;37:2215-38.
16. Narins CR, Miller DP, Califf RM, et al. The relationship between periprocedural myocardial infarction and subsequent target vessel revascularization following percutaneous coronary revascularization: insights from the EPIC trial. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic Complications. J Am Coll Cardiol 1999;33:647-53.
17. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689-96.
18. Tardiff BE, Califf RM, Tcheng JE, et al. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II. J Am Coll Cardiol 1999;33:88-96.
19. Simmons ML, Harrington R, Califf RM. Minimal myocardial damage during coronary intervention is associated with an impaired outcome. Eur Heart J 20:1112-9.
20. Harrell FE. Design: S functions for biostatistical/epidemiological modeling, testing, estimation, validation, graphics, prediction, and typesetting. Programs available at: statlib@lib.stat.cmu.edu.
21. Laskey WK. Beneficial impact of preconditioning during PTCA on creatine kinase release. Circulation 1999;99:2085-9.
22. Liu MW, Douglas JD, Lembo NJ, et al. Angiographic predictors of a rise in serum creatine kinase (distal embolization) after balloon angioplasty of saphenous vein coronary artery bypass grafts. Am J Cardiol 1993;72:514-7.
23. Kini A, Kini S, Marmur JD, et al. Incidence and mechanism of creatine kinase-MB elevation after coronary intervention with different devices. Catheter Cardiovasc Interv 1999;48:123-9.
24. Lansky AJ, Popma JJ, Leon MB, et al. Frequency and prognostic importance of creatine phophokinase myocardial isoforms after successful balloon and new device coronary angioplasty. J Invasive Cardiol 1996;8(C Suppl):3-9C.
25. Califf RM, Abdelmeguid AE, Kuntz RE, et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol 1998;31:241-51.